Foley catheter or prostaglandin E2 inserts for induction of labour at term: an open-label randomized controlled trial (PROBAAT-P trial) and systematic review of literature

被引:58
|
作者
Jozwiak, Marta [1 ]
Rengerink, Katrien Oude [2 ]
Ten Eikelder, Mieke L. G. [1 ]
van Pampus, Maria G. [3 ]
Dijksterhuis, Marja G. K. [4 ]
de Graaf, Irene M. [5 ]
van der Post, Joris A. M. [2 ]
van der Salm, Paulien [6 ]
Scheepers, Hubertina C. J. [7 ,8 ]
Schuitemaker, Nico
de Leeuwi, Jan Willem [9 ]
Mol, Ben W. J. [2 ]
Bloemenkamp, Kitty W. M. [1 ]
机构
[1] Leiden Univ, Med Ctr, NL-2300 RC Leiden, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[3] Onze Lieve Vrouw Hosp, Amsterdam, Netherlands
[4] Amphia Hosp, Breda, Netherlands
[5] Spaame Hosp, Hoofddorp, Netherlands
[6] Meander Med Ctr, Amersfoort, Netherlands
[7] Maastricht Univ, Maastricht, Netherlands
[8] Diakonessen Hosp, Utrecht, Netherlands
[9] Ikazia Hosp, Rotterdam, Netherlands
关键词
Cervical ripening; Labour induction; Foley catheter; Prostaglandin E2 insert; Caesarean section rate; DINOPROSTONE VAGINAL INSERT; BALLOON CATHETERS;
D O I
10.1016/j.ejogrb.2013.06.017
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To assess the safety and effectiveness of a transcervical Foley catheter compared to vaginal prostaglandin E2 inserts for term induction of labour. Study design: We conducted an open-label randomized controlled trial in five hospitals in the Netherlands. Women with a singleton term pregnancy in cephalic presentation, intact membranes, unfavourable cervix, and no prior caesarean section were enrolled. Participants were randomly allocated by a web-based randomization system to induction of labour with a 30 ml Foley catheter or 10 mg slow-release vaginal prostaglandin E2 inserts in a 1:1 ratio. Due to the nature of the intervention this study was not blinded. The primary outcome was the caesarean section rate. Secondary outcomes were maternal and neonatal morbidity and time from intervention to birth. Additionally, we carried out a systematic review and meta-analysis of similar studies. Results: We analyzed 226 women: 107 received a Foley catheter and 119 inserts. Caesarean section rates were comparable (20% versus 22%, RR 0.90, 95% CI 0.54-1.50). Secondary outcomes showed no differences. We observed no serious maternal or neonatal morbidity. Meta-analysis showed comparable caesarean section rates, but significantly fewer cases of hyperstimulation during the ripening phase when a Foley catheter was used. Conclusions: We found, in this relatively small study, no differences in effectiveness and safety of induction of labour with a Foley catheter and 10 mg slow release vaginal prostaglandin E2 inserts. Meta-analysis confirmed a comparable caesarean section rate, and showed fewer cases of hyperstimulation when a Foley catheter was used. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:137 / 145
页数:9
相关论文
共 50 条
  • [41] Alogliptin plus voglibose in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label, long-term extension
    Seino, Yutaka
    Fujita, Tetsuya
    Hiroi, Shinzo
    Hirayama, Masashi
    Kaku, Kohei
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 : 21 - 29
  • [42] Efficacy and safety of HSK3486 for the induction and maintenance of general anesthesia in elective surgical patients: a multicenter, randomized, open-label, propofol-controlled phase 2 clinical trial
    Zeng, Y.
    Wang, D-X
    Lin, Z-M
    Liu, J.
    Wei, X-C
    Deng, J.
    Liu, Y-F
    Ma, E-L
    Yang, M-C
    Zheng, H.
    Yu, X-D
    Guo, Q-L
    Guan, Y-J
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (04) : 1114 - 1124
  • [43] Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial
    Thaci, Diamant
    Vender, Ron
    de Rie, Menno A.
    Conrad, Curdin
    Pariser, David M.
    Strober, Bruce
    Vanvoorden, Veerle
    Wang, Maggie
    Madden, Cynthia
    de Cuyper, Dirk
    Kimball, Alexa B.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188 (01) : 22 - 31
  • [44] Efficacy and safety of alogliptin added to sulfonylurea in Japanese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial with an open-label, long-term extension study
    Seino, Yutaka
    Hiroi, Shinzo
    Hirayama, Masashi
    Kaku, Kohei
    JOURNAL OF DIABETES INVESTIGATION, 2012, 3 (06) : 517 - 525
  • [45] Efficacy and safety of alogliptin added to pioglitazone in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label long-term extension study
    Kaku, K.
    Itayasu, T.
    Hiroi, S.
    Hirayama, M.
    Seino, Y.
    DIABETES OBESITY & METABOLISM, 2011, 13 (11): : 1028 - 1035
  • [46] Efficacy and safety of alogliptin added to metformin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label, long-term extension study
    Seino, Y.
    Miyata, Y.
    Hiroi, S.
    Hirayama, M.
    Kaku, K.
    DIABETES OBESITY & METABOLISM, 2012, 14 (10): : 927 - 936
  • [47] Short-term effect of polyethylene glycol loxenatide on weight loss in overweight or obese patients with type 2 diabetes: An open-label, parallel-arm, randomized, metformin-controlled trial
    Cai, Hongyu
    Chen, Qianqian
    Duan, Yale
    Zhao, Yue
    Zhang, Xiujuan
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [48] THE EFFECTS OF SHORT-TERM EXENATIDE ON CIRCULATING ADIPONECTIN LEVELS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (DMT2) WITH OR WITHOUT NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD): A RANDOMIZED, OPEN-LABEL, CONTROLLED INTERVENTION TRIAL
    Savvidou, S.
    Karatzidou, K.
    Gagalis, A.
    Tsakiri, K.
    Hytiroglou, P.
    Goulis, J.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S720 - S721
  • [49] Efficacy and safety of alogliptin added to insulin in Japanese patients with type 2 diabetes: a randomized, double-blind, 12-week, placebo-controlled trial followed by an open-label, long-term extension phase
    Kaku, Kohei
    Mori, Mikiko
    Kanoo, Tatsuhiro
    Katou, Masafumi
    Seino, Yutaka
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (15) : 2121 - 2130
  • [50] Circulating adiponectin levels in type 2 diabetes mellitus patients with or without non-alcoholic fatty liver disease: Results of a small, open-label, randomized controlled intervention trial in a subgroup receiving short-term exenatide
    Savvidou, Savvoula
    Karatzidou, Kyparissia
    Tsakiri, Kalliopi
    Gagalis, Asterios
    Hytiroglou, Prodromos
    Goulis, John
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 113 : 125 - 134